Aim: Local anesthetic (LA) drugs are used frequently today. Incorrect administration and dose are the most common causes of toxicity. In recent years, it has been reported that lipid emulsion infusions have been used successfully in toxicity states that do not respond to standard resuscitation practices. The purpose of this study is to examine the knowledge of surgical physicians about LAs and LATS (local anesthetic toxicity syndrome) and to raise awareness about toxicity and treatment. Materials and Methods: Surgical physicians other than anesthetists working in our hospital were included in our study. We asked 14 questions including age, gender, branch, specialty year, their preferred LA and method, methods to prevent toxicity, early and late findings and treatment of toxicity. Survey questions were directed to 108 physicians and 17 of them were excluded from the study because all questions were not answered, 91 survey results were evaluated. Results: 9 physicians attended our study. The highest participation was General Surgery with a rate of 44%, 68% of them were specialists, and those with more than 10 years of work in the profession were the highest with 31.9%.It was found that the most preferred LA was lidocaine. It was observed that more than two uses per week were most common and the most common form of administration was subcutaneous / intramuscular injection.78% were using appropriate doses of drugs. The question of early signs of toxicity was the most frequent allergy, while in the late findings, cardiac arrest was the most common. In the treatment, symptomatic treatment took the first place. When lipid use was questioned in LA toxicity,61.6% of physicians stated that they had never heard of it. Conclusion: It was determined that surgical physicians who performed LA did not have sufficient information about LATS findings, symptoms and toxicity treatment methods, and we think that knowing and treating LATS is important in ensuring patient safety and preventing complications.